Sei Investments CO Achilles Therapeutics PLC Transaction History

Sei Investments CO

  • $74.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$2.26 - $3.38 $34,935 - $52,248
15,458 Added 65.59%
39,027 $88,000
Q2 2022

Aug 15, 2022
BUY
$1.96 - $3.04 $46,195 - $71,649
23,569 New
23,569 $59,000
Q3 2021

Nov 12, 2021
SELL
$5.81 - $9.93 $94,238 - $161,064
-16,220 Closed
0 $0
Q2 2021

Aug 06, 2021
BUY
$9.79 - $17.86 $158,793 - $289,689
16,220 New
16,220 $159,000

Others Institutions Holding ACHL

# of Institutions
24
Shares Held
24.3M
Call Options Held
0
Put Options Held
0
View Full List

About Achilles Therapeutics plc

ACHL Quotes by TradingView
  • Ticker ACHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,774,000
  • Market Cap $47.3M
  • Description
  • Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...
More about ACHL
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email